I guess we have different opinions here... I hope that the board and management of BLT get to read all of these posts to ensure they are aware of current shareholder sentiment (both positive and negative)... because IT IS THEIR JOB to be aware of this!!!
Just like...
IT IS THEIR JOB to inform shareholders where the company has not met its expected timeframes for pipeline milestones;
IT IS THEIR JOB to rectify issues and communicate outcomes to relevant shareholders in a timely manner;
IT IS THEIR JOB to manage risk in a manner that stops us all having to be expressing our concerns in this public forum;
IT IS THEIR JOB to justify their excessive salaries through exceptional levels of performance within their nominated positional roles!
None have been forthcoming!!!
What type of public company model encourages a lack of transparency, lack of communication and (what are clearly perceived by shareholders to be) arrogant public announcements Daynos? If PF doesn't have thick enough skin to take this criticism of his performance on board (and do something about it), than I would suggest he is in the wrong job!
I really don't care if they deliver a $200M licensing agreement next week or the week after... PF may be an exceptional scientist, but he will be remembered as a novice in corporate management circles!
- Forums
- ASX - By Stock
- BLT
- trading halt
trading halt, page-17
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online